Case of HER2neu+ Invasive Pleomorphic Lobular Carcinoma With Response to Conventional Neoadjuvant Chemotherapy: A Viable Option for an Exceedingly Rare Breast Cancer Type.

导出 LinkOut

翻译打印收藏纠错

第一作者： Blessie,Nelson

第一单位： Department of Hematology and Medical Oncology, University of Texas Medical Branch, Galveston, USA.

作者： Blessie,Nelson ^[1] ; Ashley M,Brizendine ^[1] ; Rachelle,Gietzen ^[2] ; Rohit,Venkatesan ^[3]

作者单位： Department of Hematology and Medical Oncology, University of Texas Medical Branch, Galveston, USA. ^[1] Department of Pathology, University of Texas Medical Branch, Galveston, USA. ^[2] Department of Hematology and Oncology, University of Texas MD Anderson Cancer Center, Galveston, USA. ^[3]

关键词 invasive pleomorphic lobular breast carcinoma neoadjuvant chemotherapy tchp

DOI 10.7759/cureus.11108

PMID 33240704

发布时间 2020-11-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Cureus

2020年12卷10期

e11108页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Case of HER2neu+ Invasive Pleomorphic Lobular Carcinoma With Response to Conventional Neoadjuvant Chemotherapy: A Viable Option for an Exceedingly Rare Breast Cancer Type.

Cureus

相似文献

Cureus

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Case of HER2neu+ Invasive Pleomorphic Lobular Carcinoma With Response to Conventional Neoadjuvant Chemotherapy: A Viable Option for an Exceedingly Rare Breast Cancer Type.

Cureus

相似文献

Cureus

相关期刊

检索历史清除